Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Titel:
Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial
Auteur:
Zhang, Yanjun Zeng, Gang Pan, Hongxing Li, Changgui Hu, Yaling Chu, Kai Han, Weixiao Chen, Zhen Tang, Rong Yin, Weidong Chen, Xin Hu, Yuansheng Liu, Xiaoyong Jiang, Congbing Li, Jingxin Yang, Minnan Song, Yan Wang, Xiangxi Gao, Qiang Zhu, Fengcai